TY  - JOUR
AU  - Municio, Cristina 
AU  - Dominguez-Soto, Ángeles 
AU  - Fuentelsaz-Romero, Sara 
AU  - Lamana Domínguez, Amalia
AU  - Montes, Nuria 
AU  - Cuevas, Víctor 
AU  - García Campos. Raquel 
AU  - Pablos Álvarez, José Luis
AU  - González-Álvaro, Isidoro 
AU  - Puig-Kröger, Amaya 
PY  - 2018
DO  - 10.1136/annrheumdis-2017-212537
SN  - 0003-4967
UR  - https://hdl.handle.net/20.500.14352/94316
T2  - Annals of Rheumatic Diseases
AB  - OBJECTIVES: Methotrexate (MTX) is the anchor drug for treatment of rheumatoid arthritis (RA), but the mechanism of its anti-inflammatory action is not fully understood. In RA, macrophages display a proinflammatory polarisation profile that resembles...
LA  - eng
M2  - 752
PB  - BMJ Publishing Group
TI  - Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
TY  - journal article
VL  - 77
ER  -